Chromosome Deletion

"Chromosome Deletion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Actual loss of portion of a chromosome.

Descriptor ID	D002872
MeSH Number(s)	C23.550.210.050.500.500 G05.365.590.029.530.175 G05.365.590.175.050.500.500 G05.365.590.762.180 G05.558.800.180 G05.700.131.500.500
Concept/Terms	Chromosome Deletion Chromosome Deletion Deletion, Chromosome Deletions, Chromosome Partial Monosomy Partial Monosomy Monosomies, Partial Partial Monosomies Monosomy, Partial

Below are MeSH descriptors whose meaning is more general than "Chromosome Deletion".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Chromosome Aberrations [C23.550.210]
Aneuploidy [C23.550.210.050]
Monosomy [C23.550.210.050.500]
Chromosome Deletion [C23.550.210.050.500.500]
Biological Sciences [G]
Genetic Phenomena [G05]
Genetic Variation [G05.365]
Mutation [G05.365.590]
Allelic Imbalance [G05.365.590.029]
Loss of Heterozygosity [G05.365.590.029.530]
Chromosome Deletion [G05.365.590.029.530.175]
Chromosome Aberrations [G05.365.590.175]
Aneuploidy [G05.365.590.175.050]
Monosomy [G05.365.590.175.050.500]
Chromosome Deletion [G05.365.590.175.050.500.500]
Sequence Deletion [G05.365.590.762]
Chromosome Deletion [G05.365.590.762.180]
Mutagenesis [G05.558]
Sequence Deletion [G05.558.800]
Chromosome Deletion [G05.558.800.180]
Ploidies [G05.700]
Aneuploidy [G05.700.131]
Monosomy [G05.700.131.500]
Chromosome Deletion [G05.700.131.500.500]

Below are MeSH descriptors whose meaning is related to "Chromosome Deletion".

Below are MeSH descriptors whose meaning is more specific than "Chromosome Deletion".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Chromosome Deletion" by people in this website by year, and whether "Chromosome Deletion" was a major or minor topic of these publications.

Bar chart showing 30 publications over 20 distinct years, with a maximum of 3 publications in 1997 and 2002 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	2	0	2
1997	3	0	3
1998	0	1	1
1999	1	0	1
2000	0	1	1
2001	1	0	1
2002	2	1	3
2004	1	0	1
2008	2	0	2
2009	0	1	1
2011	1	1	2
2012	1	0	1
2013	1	2	3
2014	2	0	2
2015	0	1	1
2016	0	1	1
2017	0	1	1
2019	0	1	1
2020	0	1	1

Below are the most recent publications written about "Chromosome Deletion" by people in Profiles.

Alnahhas I, Rayi A, Thomas D, Ong S, Giglio P, Puduvalli V. False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.

View in: PubMed
Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, Zagzag D, Golfinos JG, Placantonakis DG, Rosenblum M, Ohman-Strickland P, Hameed M, Snuderl M. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019 09 06; 21(9):1164-1174.

View in: PubMed
Chhabra S, Jain S, Fowler A, Sedov V, Neppalli AK, Schandl CA, Lazarchick J. IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review. Ann Clin Lab Sci. 2017 Sep; 47(5):611-619.

View in: PubMed
Mossner M, Jann JC, Nowak D, Platzbecker U, Giagounidis A, Götze K, Letsch A, Haase D, Shirneshan K, Braulke F, Schlenk RF, Haferlach T, Schafhausen P, Bug G, Lübbert M, Ganser A, Büsche G, Schuler E, Nowak V, Pressler J, Obländer J, Fey S, Müller N, Lauinger-Lörsch E, Metzgeroth G, Weiß C, Hofmann WK, Germing U, Nolte F. Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS). Leukemia. 2016 09; 30(9):1956-9.

View in: PubMed
Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.

View in: PubMed
Smith AW, Holden KR, Dwivedi A, Dupont BR, Lyons MJ. Deletion of 16q24.1 supports a role for the ATP2C2 gene in specific language impairment. J Child Neurol. 2015 Mar; 30(4):517-21.

View in: PubMed
Dean SJ, Holden KR, Dwivedi A, Dupont BR, Lyons MJ. Acquired microcephaly in blepharophimosis-ptosis-epicanthus inversus syndrome because of an interstitial 3q22.3q23 deletion. Pediatr Neurol. 2014 Jun; 50(6):636-9.

View in: PubMed
Lin AL, Liu J, Evans J, Leuthardt EC, Rich KM, Dacey RG, Dowling JL, Kim AH, Zipfel GJ, Grubb RL, Huang J, Robinson CG, Simpson JR, Linette GP, Chicoine MR, Tran DD. Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol. 2014 Jan; 16(1):123-30.

View in: PubMed
Sarasua SM, Dwivedi A, Boccuto L, Chen CF, Sharp JL, Rollins JD, Collins JS, Rogers RC, Phelan K, DuPont BR. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome. Genet Med. 2014 Apr; 16(4):318-28.

View in: PubMed
Murray B, Wagle R, Amat-Alarcon N, Wilkens A, Stephens P, Zackai EH, Goldmuntz E, Calkins H, Deardorff MA, Judge DP. A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio-oculo-facial syndrome. Am J Med Genet A. 2013 Feb; 161A(2):371-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals